Congress moves to protect biomaterial manufacturers from lengthy and frivolous lawsuits
This article was originally published in Clinica
Executive Summary
The key US House Commerce Committee is expected to approve legislation this week that would protect biomaterial manufacturers from being included in frivolous product liability lawsuits involving allegedly faulty implanted medical devices.